SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------------
FORM 8-K/A
Amendment No. 1
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): February 5, 2002 (January 29, 2002)
NORLAND MEDICAL SYSTEMS, INC.
(Exact name of Company as specified in its charter)
DELAWARE File Number 0-26206 06-1387931
(State or other jurisdiction of (Commission File Number) (I.R.S. Employer
incorporation or organization) Identification No.)
106 Corporate Park Drive, Suite 106, White Plains, NY 10604
(Address of principal executive offices) (Zip Code)
Company's telephone number, including area code: (914) 694-2285
TOTAL NUMBER OF PAGES - 3
ITEM 4(A). CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT.
- --------- ----------------------------------------------
Norland Medical Systems, Inc. (the "Company") is filing herewith the
letter from Deloitte & Touche LLP, dated February 6, 2002, addressed to the
Securities and Exchange Commission ("Commission"), stating that it agrees with
the statements made by the Company in Item 4 of its Form 8-K filed with the
Commission on February 5, 2002.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
- ------ ----------------------------------
EXHIBIT NO. DESCRIPTION
- ----------- -----------
16 Letter from Deloitte & Touche LLP to the Commission re:
change in certifying accountant
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Company has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
February 21, 2002
NORLAND MEDICAL SYSTEMS, INC.
-----------------------------
(Company)
/s/ Reynald G. Bonmati
------------------------------------------
Reynald G. Bonmati
President
2